Xcout Intel
TreeFrog Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to TreeFrog Therapeutics among biotech companies — ranked by similarity to what TreeFrog Therapeutics actually does, not by market-cap band.
Subscribe to see TreeFrog Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About TreeFrog Therapeutics
TreeFrog Therapeutics is a French-based biotech company headquartered in Pessac, France. It aims to make iPS-derived cell therapies safer, more efficient, and more affordable to cure millions of patients.
TreeFrog Therapeutics at a glance
TreeFrog Therapeutics is a biotech company headquartered in France. Xcout tracks 18 named people at TreeFrog Therapeutics, including Mark Rothera (Chief Executive Officer).
TreeFrog Therapeutics leadership
- Mark RotheraChief Executive Officer
- Michaël Lanero FidalgoChief Operating Officer
- François GianelliChief Regulatory & Quality Officer
- Jens SchröderChief Medical Officer
- Lauriane GillardChief Legal & IP Officer
- Myriam MakhloufiChief Strategy Officer
12 more named people on record for TreeFrog Therapeutics, with roles, board committees and tenure — see the full roster →
Top 12 TreeFrog Therapeutics competitors
Ranked by semantic similarity — how close each company is to TreeFrog Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Biotechnology
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Biotechnology
Kenai Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California. The company pioneers next-generation therapeutic approaches by leveraging induced pluripotent stem cell (iPSC) technology.
Biotechnology
NutrigeneAI Biotech Limited is an iPSC cell therapy platform operating in Hong Kong. The company focuses on biotechnology research and development, maintaining pipeline therapies and regional office operations.
Biotechnology
Ferring Ventures is a research company based in Kuopio, Finland, specializing in the translational field of cell therapy. The organization focuses on the discovery, establishment, and development of Advanced Therapy Medicinal Products (ATMPs) through Phase I and IIa clinical trials.
Similar biotech company
Egle Therapeutics SAS is a clinical-stage biotechnology company headquartered in Paris, France, that develops precision medicines designed to modulate regulatory T cells.
Biotechnology
Cynata Therapeutics is a biotechnology research company headquartered in Cremorne, Australia, focused on therapeutic products and stem cell technology.
Healthcare Biotech
HemostOD is a preclinical-stage biotech company based in Lausanne, Switzerland, pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets to save lives.
Biotechnology
Walking Fish Therapeutics develops cell-based therapeutics by engineering B cells to act as protein factories for the treatment of serious diseases, including oncology, regenerative medicine, autoimmune diseases, and rare deficiency diseases. The company utilizes a proprietary B cell platform to deliver various therapeutic proteins such as replacement proteins, immune-inhibitory proteins, and engineered antibodies.
Biotechnology
Kadimastem Ltd. is a clinical-stage cell therapy company headquartered in Ness Ziona, Israel, focused on developing advanced cell-based therapeutic treatments.
Similar biotech company
Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipeline includes several product candidates currently undergoing development. Among these is UCART19, an allogeneic T-cell therapy targeting CD19-expressing blood cancers such as acute lymphoblastic leukemia. Other key developments encompass ALLO-501 and ALLO-501A, designed for diffuse large B-cell lymphoma and follicular lymphoma in relapsed or refractory patients; ALLO-316, intended for Renal Cell Carcinoma; UCART123 for acute myeloid leukemia; and UCART22 for B-cell acute lymphoblastic leukemia. Furthermore, UCARTCS1 and ALLO-715 are being developed to combat multiple myeloma. Strategic partnerships form a crucial part of its operations, encompassing alliances with entities such as Allogene Therapeutics, Inc., Les Laboratoires Servier, The University of Texas M.D. Anderson Cancer Center, and Iovance Biotherapeutics. The firm also maintains a dedicated research and development collaboration with Cytovia Therapeutics, Inc. Established in 1999, Cellectis S.A. maintains its principal offices in Paris, France.
Similar biotech company
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of TreeFrog Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for TreeFrog Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →